Avandia Linked to Heart Attack Risk
A recent article in the New England Journal of Medicine reported a study indicating a 48% increased risk of heart attack with the diabetes drug Avandia. Avandia is taken by more than over 1 million people and generated sales of over $3 billion for GlaxoSmithKline last year.
Could this be another Vioxx? Well, not to the same scale, but the author of the recent study, Dr. Steven Nissin, was one of the main critics of Vioxx. We will have to wait to see just how much Glaxo new before this study came out.
Read more at WSJ.com.
Post A Comment / Question